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Abstract 
Background: Clear-cell carcinoma arising from the surgical cesarean section scar is very infrequent. The present 
study reports two patients with clear-cell carcinoma arising from an abdominal wall scar 20 and 23 years after their 
last cesarean section.
Case presentation: Both Iranian patients had prior cesarean sections nearly 20 years earlier. Patients 1 and 2 had 
transverse and vertical abdominal incisions, respectively. The initial clinical presentation was a huge lower abdominal 
mass at the site of the previous cesarean section scar. Both patients underwent abdominal wall mass biopsy. The 
histological analysis revealed the presence of malignancy. Both patients underwent full-thickness resection of the 
abdominal wall mass. All surgical margins were tumor-free; however, patient 1 had a very narrow tumor-free margin 
near the pubic symphysis. As the imaging report of patient 2 revealed the presence of a pelvic mass, the exploration 
of the intraperitoneal space, simple total abdominal hysterectomy (TAH), bilateral salpingo-oophorectomy (BSO), 
and the excision of enlarged pelvic lymph nodes were performed during the surgery. Six cycles of paclitaxel and 
carboplatin every 3 weeks as adjuvant chemotherapy was administered for both patients after the surgery. One of the 
patients had disease recurrence 5 months after the termination of chemotherapy, and the other is still disease-free. 
These two patients had similar pathology and received a similar initial adjuvant treatment; however, they were differ-
ent in terms of the direction of tumor spread, tumor distance from the pubic symphysis, status of tumor margins, and 
surgical procedures.
Conclusions: We encountered distinct prognoses in the clear-cell carcinoma of cesarean section scars presented 
herein. The researchers can recommend complete surgical excision of the abdominal wall mass with wide tumor-free 
margins, exploration of the abdominopelvic space, TAH, and BSO during the first surgery.
Keywords: Clear-cell carcinoma, Endometriosis, Abdominal wall, Surgical site, Cesarean section scar
© The Author(s) 2021, corrected publication 2021. Open Access This article is licensed under a Creative Commons Attribution 4.0 
International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you 
give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes 
were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated 
otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not 
permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To 
view a copy of this licence, visit http:// creat iveco mmons. org/ licen ses/ by/4. 0/. The Creative Commons Public Domain Dedication waiver 
(http:// creat iveco mmons. org/ publi cdoma in/ zero/1. 0/) applies to the data made available in this article, unless otherwise stated in a 
credit line to the data.
Background
Endometriosis is one of the most frequent conditions 
in reproductive-aged women, with a prevalence rate of 
at least 10–15% [1]. Endometriosis has been defined as 
the abnormal growth of endometrial tissues outside the 
uterus. Abdominal wall endometriosis (AWE) has typi-
cally been observed in patients undergoing gynecological 
surgeries such as caesarian section and hysterectomy [2, 
3]. Malignant transformation of extra-ovarian endome-
triosis is infrequent [4, 5]. The risk of the transformation 
of endometriosis to a malignant disease is currently esti-
mated to be 0.3–1.0% [6]. Clear-cell carcinoma is the sec-
ond most frequent histological variant, and endometrioid 
carcinoma [7]. Abdominal wall clear-cell carcinoma is 
an extremely rare event. Following the documentation 
of the first case in 1986 [8], only a few cases have been 
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reported to date. Based on the published studies in the 
literature, the time lag from the first surgery to the diag-
nosis of malignancy is 6–20 years [4, 5]. The management 
of abdominal wall clear-cell carcinoma has not been well 
attended to because this tumor is extremely rare and the 
published literature is not rich in this regard. We report 
two patients with clear-cell carcinoma in the lower 
abdominal wall at the site of their previous cesarean sec-
tion scar. Patient 1 had a history of abdominal cesarean 
scar endometriosis before menopause; however, we did 
not have any records for the endometriosis of patient 2. 
Standard written informed consent was obtained from 




A 53-year-old postmenopausal Iranian woman pre-
sented to the hospital for a progressively growing pain-
ful cesarean scar mass. Her personal history included 
three previous Pfannenstiel cesarean sections without 
any medical diseases. The last cesarean section was per-
formed 23 years earlier. Pfannenstiel scars were adjacent 
to her pubic symphysis. She had no family history of 
gynecological malignancy. She previously had bloody dis-
charge during her menstrual cycle from a very small ori-
fice inside the abdominal cesarean scar for 16 years. The 
monthly bloody discharge was stopped after her meno-
pause. She detected a mass that was approximately 3 cm 
in diameter during her self-examination of her cesar-
ean scar 3 years after menopause. The mass was con-
verted to a huge one over 3 months (Fig. 1). On physical 
examination, a significant large, firm, and fixed mass was 
observed in her suprapubic Pfannenstiel cesarean scar 
and extended upward to the anterior abdominal wall. 
An abdominopelvic computed tomography (CT) scan 
revealed a 9.1 × 5.6 × 4.7 cm heterogeneous solid mass 
with a cystic component in the lower part of the rectus 
muscle. The observed mass expanded to the subcutane-
ous tissue, with close contact with the pubic symphysis, 
and extended to the retropubic space. Other pelvic and 
abdominal organs were observed to be normal in the 
first imaging (Fig. 2). Needle biopsy of the mass was per-
formed under ultrasound guidance. Histology revealed 
an undifferentiated carcinoma. Thorax CT scan, colonos-
copy, upper gastrointestinal endoscopy, mammography, 
and transvaginal ultrasound were all normal. The patient 
was scheduled for complete excision of the abdominal 
wall mass as determined by the cancer multidiscipli-
nary team (MDT). A complete excision of the mass and 
its surrounding tissues was performed. The permanent 
histology revealed clear-cell carcinoma arising from the 
Pfannenstiel cesarean scar (Fig. 3). Permanent pathologi-
cal reports indicated negative excision margins; however, 
the tumor was very close to the surgical margin in the 
lower part of the mass adjacent to the pubic symphysis 
(1 mm).
Thirty days after the surgery, the patient initiated 
chemotherapy with six cycles of paclitaxel and carbo-
platin every 3 weeks. To follow up, an abdominopelvic 
ultrasound was performed 3 months after the last chem-
otherapy treatment. Ultrasound was normal. The patient 
was asymptomatic nearly 5 months after the termination 
of chemotherapy. However, she had abdominal discom-
fort later on. Positron emission tomography–computed 
tomography (PET-CT) was performed 5 months after the 
last chemotherapy treatment (Fig.  4) and demonstrated 
Fig. 1 A huge mass originating from the horizontal cesarean scar 
in patient. Black spots show the margins of the mass. The site of 
previous orifice is marked by an arrow. Pfannenstiel scars are very 
close to the pubic symphysis
Fig. 2 Preoperative pelvic computed tomography scan of patient 1. 
Borders of the abdominal wall mass are marked by arrows
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ascites and recurrences in the abdominal wall, retropu-
bic space, and pelvic peritoneum space. Therefore, she 
received second-line chemotherapy with four cycles of 
bevacizumab, cisplatin, and doxorubicin. She was resist-
ant to the second-line chemotherapy, and the tumor 
progressed diffusely in the abdominopelvic space dur-
ing the second-line chemotherapy course. She had severe 
abdominal pain and mainly presented gastrointesti-
nal symptoms such as nausea. It was determined by the 
MDT that the patient was a candidate for palliative ther-
apy. However, she refused the MDT decision and insisted 
on a second surgery. She had the surgery in another hos-
pital. Her second surgery consisted of total abdominal 
hysterectomy (TAH) with bilateral salpingo-oophorec-
tomy (BSO), pelvic washing, excision of the abdominal 
wall mass, segmental resection of a narrow lumen of 
the large bowel, and end-to-end anastomosis and selec-
tive large pelvic lymph node dissection. All specimens 
showed clear-cell carcinoma involvement. The patient 
received third-line chemotherapy with three cycles of 
gemcitabine and vinorelbine. She did not return to our 
center after the second surgery; however, she sent us her 
treatment records. Unfortunately, she died 20 months 
after diagnosis.
Patient 2
A 58-year-old Iranian postmenopausal woman referred 
to the hospital because of a abdominal wall mass and her-
nia. She had a history of three cesarean sections with a 
midline abdominal incision. Her last cesarean section was 
performed 20 years earlier. Physical examination demon-
strated a partially mobile and large mass in the anterior 
abdominal wall in the midline cesarean scar, extending 
bilaterally to the midclavicular line. The upper margin 
of the mass was adjacent to her umbilicus, where there 
was a large umbilical hernia above the mass (Fig. 5). Pel-
vic ultrasound showed an irregular 12 × 8 × 8 cm mass in 
the abdominal wall anterior to the rectus muscle involv-
ing subcutaneous tissue, a large umbilical hernia contain-
ing omentum, and a well-defined left solid adnexal mass 
(4.1 × 3.7 × 5.1 cm in diameter). An abdominopelvic CT 
scan confirmed the ultrasound findings (Fig. 6). The peri-
toneal surface of the anterior abdominal wall was intact, 
and other abdominal and pelvic organs were normal. The 
chest X-ray was normal.
A local incisional biopsy of the abdominal wall mass 
was performed before referral to our department. The 
histology implied clear-cell carcinoma
The patient was scheduled for surgery as determined 
by the MDT. Midline laparotomy was performed. The 
abdominal wall mass invaded the lower half of the rectus 
muscles. The mass reported in the left adnexa was indeed 
a large pelvic lymph node adjacent to the left external 
iliac artery. Uterus and ovaries had a normal appearance. 
The patient underwent a complete excision of the abdom-
inal wall mass including the rectus muscles and fascia, 
peritoneal washing, resection of the enlarged pelvic 
lymph nodes, TAH, and BSO. Due to the large abdominal 
wall defect following the excision of the abdominal wall 
mass, reconstructive surgery was performed to repair 
the abdominal wall. The defect was covered with a syn-
thetic mesh. The results of the permanent histology of 
the abdominal wall mass and the enlarged pelvic lymph 
node were similar, indicating clear-cell carcinoma (Fig. 7) 
without any marginal involvement. The pathology results 
of ascites and surgical specimens were negative. Twenty 
days after the reconstructive surgery, the patient initiated 
chemotherapy with six cycles of paclitaxel and carbopl-
atin every 3 weeks. An abdominopelvic CT scan was per-
formed 6 months after the completion of the treatment 
and revealed normal findings. At present, the patient is 
Fig. 3 Clear-cell carcinoma of the abdominal scar. Malignant glands 
are lined by anaplastic hobnail cells with clear cytoplasm
Fig. 4 Positron emission tomography–computed tomography 5 
months after the first-line chemotherapy. Lower abdominal wall and 
pelvic peritoneal tumoral involvement
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alive without any recurrence (26 months after diagnosis). 
The basic characteristics of the patients, imaging results, 
surgical procedure, and adjuvant treatment are summa-
rized in Table 1.
Discussion
Clear-cell carcinoma of the abdominal wall that devel-
ops in cesarean section scars is an extremely rare condi-
tion. Endometriosis of a cesarean section scar or close 
contact of the abdominal wall with the endometrium of 
cesarean incision may be a risk factor for the develop-
ment of abdominal wall clear-cell carcinomas. The inci-
dence of scar endometriosis that is usually the result 
of a normal endometrial tissue implantation following 
gynecological or obstetric surgery has been reported to 
be 0.03–0.4% [8, 9]. The combination of oxidative stress 
due to inflammation, chronic hemorrhage, and estro-
gen excess seems to play a role in the tumorigenesis of 
endometriosis-related neoplasms [9]. Transformation 
of abdominal wall endometriosis to malignancy is very 
rare. The malignant transformation of endometriosis 
within surgical scars is uncommon [10], and the rate of 
surgical scar endometriosis in the abdominal wall has 
been estimated to be up to 1% [6, 9].
In the present study, our patients had a history 
of cesarean section nearly 20 years earlier. The first 
and second patients had transverse and vertical inci-
sions, respectively. The spreading pattern of tumors 
Fig. 5 A huge mass originating from the vertical cesarean scar in patient 2. a Borders of the abdominal wall mass are marked by white arrows. The 
black arrow shows the abdominal wall hernia. b Total excision of the mass
Fig. 6 Preoperative pelvic computed tomography scan of patient 2. 
Borders of the abdominal wall mass are marked by white arrows. The 
black arrow indicates the pelvic mass
Fig. 7 Clear-cell carcinoma of the abdominal scar. Malignant glands 
are lined by anaplastic hobnail cells with clear cytoplasm
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was along the direction of the incisions. Transverse 
spread of tumor along the Pfannenstiel incision scar 
was observed in the first patient, whereas longitudinal 
tumor spread along the midline scar was observed in 
the second patient. These findings are in accordance 
with the fact that scar endometriosis is an iatrogenic 
transplantation of endometrial tissues during delivery 
or gynecological surgery and is not a metaplastic phe-
nomenon [6].
Due to the rarity of abdominal wall endometriosis and 
transformation of endometriosis to clear-cell carcinoma, 
the optimal treatment still remains unclear. To date, 
about 30 abdominal wall clear-cell carcinomas originat-
ing from endometriosis cases have been reported in the 
world literature. Taburiaux et al. reviewed 27 cases of 
cancer arising from abdominal wall endometriosis and 
reported 18 patients with clear-cell carcinomas  [7]. In a 
retrospective review, Lai et al. [11], thoroughly described 
six cases of pathologically confirmed clear-cell carci-
noma originating from the abdominal wall that were 
encountered at their institution over a 15-year period. 
They concluded that complete resection of the abdomi-
nal wall tumor and suspected intra-abdominal lesions, as 
well as hysterectomy and bilateral inguinal lymph node 
dissection, may be suggested as the first step toward its 
treatment. They recommended adjuvant chemotherapy 
because of its potential benefits. To achieve complete 
resection, a surgical procedure such as advanced ovar-
ian cancer surgery may be considered. The surgical plan-
ning may include optimal cytoreduction (no residue) and 
repair of the abdominal wall defect [12].
In our study, only the complete excision of the abdomi-
nal wall mass was performed for the first patient at 
primary surgery, while the second patient underwent 
TAH, BSO, pelvic washing, and complete excision of the 
abdominal wall mass and enlarged pelvic lymph nodes. 
As the first patient had cancer recurrence, perhaps it can 
be claimed that the difference in surgical treatment was 
one of the main factors in the recurrence of the clear-cell 
carcinoma. Hence, it seems that wide local excision of the 
abdominal wall tumor with TAH and BSO and the explo-
ration of the abdominopelvic space should be preferred 
during the first surgery. Any imaging is not 100% accu-
rate. Pelvic dissection is also recommended to predict 
distant metastasis and poor outcome if any positive node 
is present [9].
Tumor resection with a wide tumor-free margin may 
be essential for the treatment of an abdominal wall mass. 
Surgical margins were different in our two patients, as 
follows: completely negative and wide (more than 1.5 cm) 
in the second patient and very narrow in the first patient 
(1 mm). Therefore, we recommend a wide tumor-free 
Table 1 Clinicopathological characteristics of two patients with clear-cell carcinoma of abdominal wall cesarean section scars
BMI body mass index, CT computed tomography, TAH total abdominal hysterectomy, BSO bilateral salpingo-oophorectomy, BPLND bilateral pelvic lymph node 
dissection
Characteristics Patient 1 Patient 2
Age at diagnosis (years) 53 58
BMI (kg/m2) 35.4 26.6
Parity 3 3
Tumor size (cm) 9.1 × 5.6 × 4.7 12 × 8 × 8
Type of cesarean abdominal wall incision, no. of times Pfannenstiel, 3 times Vertical, 3 times
Symptom Lower abdominal wall mass Lower abdominal wall mass
Mobility of mass Fixed to pubic symphysis Partially mobile
Time from the last cesarean to disease diagnosis (years) 23 20
Preoperative CT scan results Lower abdominal wall mass Lower abdominal wall mass
Left solid adnexal mass (lymph node)
Umbilical hernia
First surgery Total abdominal wall mass excision Total abdominal wall mass excision
TAH, BSO, selective large BPLND
Surgical margins of the abdominal wall mass Free but narrow (1 mm) Free and wide (more than 1 cm)
Time from the first surgery to recurrence (months) 9.5 No recurrence







Colon surgery (partial obstruction)
No
Current status Died of disease Alive without recurrence
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surgical margin if possible. It may be that the resection 
of pubic symphysis during the first surgery of patient 1 
resulted in a better prognosis. Moreover, the excision of 
the lesion adjacent to bone is difficult even in endome-
triosis of abdominal wall cesarean scars.
These two patients had similar pathology and adjuvant 
treatments; however, they were different in terms of the 
direction of tumor spread, proximity to the pubic symph-
ysis, state of margins, exploration of the intraperitoneal 
space, and performance of TAH and BSO during the first 
surgery. These differences may have resulted in distinct 
prognoses for these two patients.
The role of postoperative chemotherapy is not yet well 
established. Platinum-based chemotherapy has most 
often been used [6, 9].
Conclusion
Distinct prognoses were experienced with respect to the 
clear-cell carcinoma of cesarean section scars presented 
herein. Based on the findings, complete surgical excision 
of the abdominal wall mass with wide tumor-free mar-
gins, exploration of the abdominopelvic space, TAH, and 
BSO during the first surgery can be recommended.
To summarize, additional studies are needed to estab-
lish a standard treatment in the management of clear-cell 
carcinoma of cesarean section scars and to benefit from 
adjuvant treatments.
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